Temedica

Crafting the future of personal health

Every patient and their journey is unique — just like a fingerprint. Focusing on the patient requires individual therapies and approaches to treatment, and each patient’s story has the unique potential to teach us something new about the disease and helps us discover more effective solutions.


At Temedica, we believe that individualized treatment is a fundamental right of every patient, and is key to an overall improved quality of patient care. Today’s "one-size-fits-all" approach to medical care ignores the many different and unique patient journeys and experiences and stands in the way of optimal care. This is a challenge that we aim to overcome.

About us

About Temedica

Temedica is a Munich, Germany-based digital health and health insights company with the mission to bring the patient into the center of healthcare. The company develops state-of-the-art digital patient companions for complex, chronic conditions. These apps support patients with personalized guidance and help them navigate healthcare systems by considering their individual needs. Through direct and long-term interaction with patients, Temedica generates unique and previously unknown real-world evidence about disease progression and the individual effectiveness of therapies. 

Temedica is supported by a consortium of renowned investors with longstanding track-records in the biopharmaceutical industry, including the founding investors of BioNTech. 

Real-world evidence and longitudinal patient-generated insights

Temedica gains unique understanding to enable predictive, preventative, personalized and participatory medicine.

The model
Temedica Apps

Temedica Apps

Our Temedica App platform technology provides indication-specific digital companion apps that are tailored to each patient’s needs. We provide a wide variety of services for different requirements and therapeutic areas, accompanying clinical studies as well as digital patient support and standalone digital therapeutics. Our apps are based on consistent quality management and meet all regulatory requirements (MDR, FDA).

www.temedica-apps.com arrow_right

Permea

Permea

Permea delivers previously unknown insights for the life science industry, providing actionable knowledge to enable well-informed decisions. Our intelligence is based on our proprietary, anonymized patient-generated data, which we combine with other verified relevant data types.

www.permea-health.com arrow_right

Hundreds of thousands of patients use our Digital Companions

Temedica offers patient-centric digital companions in the form of apps for an ever-growing range of indications. These mobile apps accompany patients on their health journey and support them with personalized, therapy-supporting guidance. 

 

www.temedica-apps.comarrow_right
pelvina

pelvina

Digital Therapeutics
Pelvic Floor Health

pelvina daily

pelvina daily

Patient Companion
Pelvic Floor Health

Waya

Waya

Patient Companion
Obesity & Type 2 Diabetes

Brisa

Brisa

Patient Companion
Multiple Sclerosis

Ilio

Ilio

Patient Companion and Trial Companion
Axial Spondyloarthritis (AxSpA)

Ascalate

Ascalate

Trial Companion
Axial Spondyloarthritis (AxSpA)

Psoriasis Buddy

Coming Soon

Patient Companion
Psoriasis

more

And more coming soon…

CalltoAction

If you are interested in our products and services - or for a reference interview with one of our partners - please contact us.

Contact us